MedTrace Logo

Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.

NCT04765215 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 291

Last updated 2021-06-11

No results posted yet for this study

Summary

This study aimed to investigate the effectiveness of CoronaVac vaccine, which is more than 90% protective in healthy people, in cancer patients receiving active chemotherapy. In this study, to collect information to measure the amount of antibodies produced by the vaccine in the blood of volunteers with the CoronoVac vaccine and to compare it with healthy volunteers.

Conditions

  • Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy

Interventions

BIOLOGICAL

CoronoVAC

SARS-CoV-2 IgM and IgG will be measured from blood samples between 3-6 weeks after the 2nd dose of vaccination

Sponsors & Collaborators

  • Asoc. Prof. Erdoğan Selçuk Şeber

    lead OTHER

Principal Investigators

  • Erdoğan Selçuk Şeber, Asoc.prof · Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi İç Hastalıkları ABD, Tıbbi Onkoloji

  • Halil Taşkaynatan, Asoc.prof · İzmir Özel Ege Şehir Hastanesi

  • Özkan Alan, MD · Tekirdağ Dr. İsmail Fehmi Cumalıoğlu Şehir Hastanesi

  • Üyesi Sonat Pınar Kara, MD · Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi İç Hastalıkları ABD, İç Hastalıkları

  • Aliye Çelikkol, MD · Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi Tıbbi Biyokimya ABD,

  • Okan Avcı, MD · Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi İç Hastalıkları ABD, Tıbbi Onkoloji

  • Eyyüp Çavdar, MD · Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi İç Hastalıkları ABD, Tıbbi Onkoloji

  • Kubilay Karaboyun, MD · Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi İç Hastalıkları ABD, Tıbbi Onkoloji

  • Berna Erdal, DR · Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi Mikrobiyoloji ABD

  • Yakup İriağaç, MD · Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi İç Hastalıkları ABD, Tıbbi Onkoloji

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2021-07-31
Completion
2022-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04765215 on ClinicalTrials.gov